These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 33757977)

  • 1. Stomatin-Mediated Inhibition of the Akt Signaling Axis Suppresses Tumor Growth.
    Rahman NIA; Sato A; Tsevelnorov K; Shimizu A; Komeno M; Ahmat Amin MKB; Molla MR; Soh JEC; Nguyen LKC; Wada A; Kawauchi A; Ogita H
    Cancer Res; 2021 May; 81(9):2318-2331. PubMed ID: 33757977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EphA-Mediated Regulation of Stomatin Expression in Prostate Cancer Cells.
    Nishida M; Sato A; Shimizu A; Rahman NIA; Wada A; Kageyama S; Ogita H
    Cancer Med; 2024 Oct; 13(19):e70276. PubMed ID: 39377541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Inhibitor of AKT1-PDPK1 Interaction Efficiently Suppresses the Activity of AKT Pathway and Restricts Tumor Growth In Vivo.
    Mäemets-Allas K; Viil J; Jaks V
    Mol Cancer Ther; 2015 Nov; 14(11):2486-96. PubMed ID: 26294745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-to-cell contact-mediated regulation of tumor behavior in the tumor microenvironment.
    Sato A; Rahman NIA; Shimizu A; Ogita H
    Cancer Sci; 2021 Oct; 112(10):4005-4012. PubMed ID: 34420253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The inhibition of Akt-Pdpk1 interaction efficiently suppresses the growth of murine primary liver tumor cells.
    Mäemets-Allas K; Belitškin D; Jaks V
    Biochem Biophys Res Commun; 2016 May; 474(1):118-125. PubMed ID: 27103434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lemur Tyrosine Kinase-3 Suppresses Growth of Prostate Cancer Via the AKT and MAPK Signaling Pathways.
    Sun P; Sun X; Zhao W; Ren M; Zhang C; Wang Z; Xu W
    Cell Physiol Biochem; 2017; 42(6):2582-2592. PubMed ID: 28848113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. POU2F2 regulates glycolytic reprogramming and glioblastoma progression via PDPK1-dependent activation of PI3K/AKT/mTOR pathway.
    Yang R; Wang M; Zhang G; Li Y; Wang L; Cui H
    Cell Death Dis; 2021 Apr; 12(5):433. PubMed ID: 33931589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR‑16‑2‑3p inhibits cell proliferation and migration and induces apoptosis by targeting PDPK1 in maxillary primordium mesenchymal cells.
    Han T; Wu N; Wang Y; Shen W; Zou J
    Int J Mol Med; 2019 Mar; 43(3):1441-1451. PubMed ID: 30664182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knocking down FAM83B inhibits endometrial cancer cell proliferation and metastasis by silencing the PI3K/AKT/mTOR pathway.
    Lin Q; Chen H; Zhang M; Xiong H; Jiang Q
    Biomed Pharmacother; 2019 Jul; 115():108939. PubMed ID: 31079003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of FBXO31-mediated degradation of DUSP6 dysregulates ERK and PI3K-AKT signaling and promotes prostate tumorigenesis.
    Duan S; Moro L; Qu R; Simoneschi D; Cho H; Jiang S; Zhao H; Chang Q; de Stanchina E; Arbini AA; Pagano M
    Cell Rep; 2021 Oct; 37(3):109870. PubMed ID: 34686346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA PlncRNA-1 accelerates the progression of prostate cancer by regulating PTEN/Akt axis.
    Cui Z; Gao H; Yan N; Dai Y; Wang H; Wang M; Wang J; Zhang D; Sun P; Qi T; Wang Q; Kang W; Jin X
    Aging (Albany NY); 2021 Apr; 13(8):12113-12128. PubMed ID: 33848262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ERCC6L promotes the progression of hepatocellular carcinoma through activating PI3K/AKT and NF-κB signaling pathway.
    Chen H; Wang H; Yu X; Zhou S; Zhang Y; Wang Z; Huang S; Wang Z
    BMC Cancer; 2020 Sep; 20(1):853. PubMed ID: 32891122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphoinositide-dependent Kinase-1 (PDPK1) regulates serum/glucocorticoid-regulated Kinase 3 (SGK3) for prostate cancer cell survival.
    Nalairndran G; Hassan Abdul Razack A; Mai CW; Fei-Lei Chung F; Chan KK; Hii LW; Lim WM; Chung I; Leong CO
    J Cell Mol Med; 2020 Oct; 24(20):12188-12198. PubMed ID: 32926495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. As a downstream target of the AKT pathway, NPTX1 inhibits proliferation and promotes apoptosis in hepatocellular carcinoma.
    Zhao Y; Yu Y; Zhao W; You S; Feng M; Xie C; Chi X; Zhang Y; Wang X
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31113871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell adhesion molecule 4 suppresses cell growth and metastasis by inhibiting the Akt signaling pathway in non-small cell lung cancer.
    Luo F; Zhao Y; Liu J
    Int J Biochem Cell Biol; 2020 Jun; 123():105750. PubMed ID: 32325280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR‑181d promotes cell proliferation via the IGF1/PI3K/AKT axis in glioma.
    Tang D; Gao W; Yang J; Liu J; Zhao J; Ge J; Chen Q; Liu B
    Mol Med Rep; 2020 Nov; 22(5):3804-3812. PubMed ID: 33000209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of
    Zhang Y; Hu B; Li Y; Deng T; Xu Y; Lei J; Zhou J
    Autophagy; 2020 Sep; 16(9):1697-1710. PubMed ID: 31885313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial cell adhesion molecule (EpCAM) is involved in prostate cancer chemotherapy/radiotherapy response in vivo.
    Ni J; Cozzi P; Beretov J; Duan W; Bucci J; Graham P; Li Y
    BMC Cancer; 2018 Nov; 18(1):1092. PubMed ID: 30419852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible involvement of the Hedgehog and PDPK1-Akt pathways in the growth and migration of small-cell lung cancer.
    Tang N; Hu B; Zhang Y; Chen Z; Yu R
    J Int Med Res; 2021 May; 49(5):3000605211016562. PubMed ID: 34038205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GPCR48/LGR4 promotes tumorigenesis of prostate cancer via PI3K/Akt signaling pathway.
    Liang F; Yue J; Wang J; Zhang L; Fan R; Zhang H; Zhang Q
    Med Oncol; 2015 Mar; 32(3):49. PubMed ID: 25636507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.